Home/HanchorBio/Yuehua Cong, PhD

YC

Yuehua Cong, PhD

Chief Business Officer (CBO)

Therapeutic Areas

Oncology Immunology

HanchorBio Pipeline

Drug	Indication	Phase
HCB101	Gastric Cancer (HER2+), HNSCC, CRC, TNBC, SCLC	Phase 1b/2a
HCB301	Solid Tumors, Hematologic Malignancies	Phase 1
HCB303	Solid Tumors, Hematologic Malignancies	Preclinical
HCB206	Autoimmune Diseases	Preclinical

Leadership Team at HanchorBio

Scott (Shih-Gao) Liu, PhD

Founder, Chairman & CEO

Alvin (Ying-Ming) Luk, PhD, MBA, CCRA

President & Chief Medical Officer (CMO)

Alan (Mu-Zeng) Tseng, EMBA

Chief Financial Officer (CFO)

Wenwu Zhai, MD, PhD

Chief Scientific Officer (CSO) / R&D General Manager

View full HanchorBio profile